Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody i-131-CC49

Lale Kostakoglu, Chaitanya R. Divgi, Susan Hilton, Carlos Cordon-Cardo, Andrew M. Scott, Hovanes Kalaigian, Ronald D. Finn, Jeffrey Schlom, Steven M. Larson

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody i-131-CC49'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science